Exthera Medical Corporation
At a glance
Employees20-99
In business sinceNot reported
HeadquartersMartinez, CA
US patents22
SAM.gov UEIDHBMDQGDJ8S7
CAGE code5FM86
Incorporated inDE
What they make
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
22 US patents granted 2014–2024, 8 of them in the five years to SEP 2025.
Pharmaceuticals 13Chemical engineering 5Measurement 3Medical technology 1
- Method for modulating endothelial glycocalyx structureUS 12,090,261 · granted SEP 17, 2024
- Method for treating drug intoxicationUS 11,911,551 · granted FEB 27, 2024
- Method for removing bacteria from blood using high flow rateUS 11,844,895 · granted DEC 19, 2023
- Methods for diagnosing infectious diseases using adsorption mediaUS 11,306,346 · granted APR 19, 2022
- Use of heparin and carbohydrates to treat cancerUS 11,266,772 · granted MAR 8, 2022
Newest 5 shown · Granted to Exthera Medical Corporation · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Exthera Medical Corporation | Martinez | CA | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.
